Monthly Archives: July 2011

Scientific American on BRIC’s IP Environment

Scientific American World View issued a special report at this year’s 2011 BIO International Convention that had several references to IP protections around the world but focused particularly on the BRIC countries (Brazil, Russia, India, and China).  See below for interesting takes on the IP environment in each country. China: Patently Ambiguous asserts that while “China’s intellectual property environment remains challenging at best” several involved on the ground in China believe that “there should be Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

BIO Convention rookie no longer

2011 BIO International Convention Exhibition

As the saying goes, there is nothing quite like learning on the job and no truer words could be spoken about my experience with this year’s BIO International Convention. Having joined the Communications Department less than two months prior to the largest event of the year, my start date was in the height of Convention preparation. Each day at the office was consumed by learning, retaining and contributing as much as possible to the Convention Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Could 3 minutes reshape California’s biotech future?

Ron Leuty from BiotechSF writes: In just three minutes the other day, Maryland received more than 180 applications for its $8 million biotech tax credit program. The program, which rewards investors for putting cash in biotech startups, is one of many that states are offering to jumpstart or grow their life sciences communities.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Taiwan’s Translational Research (or lack thereof)

Taiwan Flag - Matthew Fang

Brady Huggett concludes in this article that, “… perhaps the biggest strike against Taiwan is a lack of translational research. There is no collective mindset that envisions products from research. And if biotech is to drive the future economies of countries around the globe, there has to be nationwide efforts to turn academic research and publicly-funded lab work into something that can benefit patients and be sold. We’ve talked about it before on this blog Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

They engineered a better salmon, so why is Congress blocking it?

Steven Salzberg from Fighting Pseudoscience writes: What happened to genetically modified salmon? A few months back I was looking forward to my first taste of the new AquaBounty salmon, which grows to maturity twice as fast as wild salmon. Will it taste just as good? Better? I thought I’d know soon. But then politics intervened. Fighting Pseudoscience is a blog from Forbes.

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,